Home Cart Sign in  
Chemical Structure| 773-76-2 Chemical Structure| 773-76-2

Structure of Chloroxine
CAS No.: 773-76-2

Chemical Structure| 773-76-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Chloroxine is a synthetic quinoline derivative with antibacterial activity, used in some shampoos for the treatment of dandruff and seborrheic dermatitis of the scalp.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Chloroxine

CAS No. :773-76-2
Formula : C9H5Cl2NO
M.W : 214.05
SMILES Code : OC1=C2N=CC=CC2=C(Cl)C=C1Cl
MDL No. :MFCD00006786
InChI Key :WDFKMLRRRCGAKS-UHFFFAOYSA-N
Pubchem ID :2722

Safety of Chloroxine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 7.24 ±0.68 μM 24 hours To validate the inhibitory effect of Chloroxine on SARS-CoV-2 PLpro, results showed it could recover cellular ISGylation levels Int J Biol Macromol. 2021 Oct 1;188:137-146.
Candida auris 0.39 µM to 0.94 µM 24 hours To evaluate the inhibitory effect of Chloroxine on Candida auris, results showed broad-spectrum inhibitory activity against multiple C. auris strains. mBio. 2023 Aug 31;14(4):e0137623.
FHs 74 Int 0.5 µg/mL 72 hours Evaluate the cytotoxicity of chloroxine against normal intestinal cells, showing cytotoxicity to FHs 74 Int cells. Pharmaceuticals (Basel). 2020 Sep 3;13(9):233.
HT29 3.7 µg/mL 72 hours Evaluate the antiproliferative activity of chloroxine against intestinal cancer cells, showing cytotoxicity to HT29 cells. Pharmaceuticals (Basel). 2020 Sep 3;13(9):233.
Caco-2 1.3 µg/mL 72 hours Evaluate the antiproliferative activity of chloroxine against intestinal cancer cells, showing cytotoxicity to Caco-2 cells. Pharmaceuticals (Basel). 2020 Sep 3;13(9):233.
Yeast cells 10−3–10 µM 2.5 hours Evaluate the blocking effect of 8HQ-based blockers on HR H2 Biosensors (Basel). 2023 May 23;13(6):571.
Rat skinned skeletal muscle fibers 100 μM To evaluate the inhibitory effect of Chloroxine on RyR1 Ca2+ leak. Results showed that 100 μM Chloroxine significantly reduced RyR1 Ca2+ leak. Sci Rep. 2020 Feb 4;10(1):1791.
Human skinned skeletal muscle fibers 100 μM To evaluate the inhibitory effect of Chloroxine on RyR1 Ca2+ leak. Results showed that 100 μM Chloroxine significantly reduced RyR1 Ca2+ leak. Sci Rep. 2020 Feb 4;10(1):1791.
HEK293T cells 1 μM To validate the ability of Chloroxine to block HRH2 in mammalian cells, results showed a significant decrease in cAMP levels at 1 μM concentration. ACS Synth Biol. 2022 Aug 19;11(8):2820-2828.
CovCis 10 μM 7 days To evaluate the synergistic effect of chloroxine with cisplatin in platinum-resistant HGSC cells. Results showed that chloroxine at 10 μM concentration synergized with cisplatin, significantly reducing cell survival. Cell Death Dis. 2021 Apr 14;12(4):395.
Ov4Carbo 10 μM 7 days To evaluate the synergistic effect of chloroxine with carboplatin in platinum-resistant HGSC cells. Results showed that chloroxine at 10 μM concentration synergized with carboplatin, significantly reducing cell survival. Cell Death Dis. 2021 Apr 14;12(4):395.
OVCAR4 10 μM 7 days To evaluate the synergistic effect of chloroxine with carboplatin in platinum-sensitive HGSC cells. Results showed that chloroxine at 10 μM concentration synergized with carboplatin, significantly reducing cell survival. Cell Death Dis. 2021 Apr 14;12(4):395.
HCT116 cells 10-50 µM 24 hours Measurement of H2S production and cell proliferation showed that chloroxine significantly reduced H2S production and inhibited cell proliferation Int J Mol Sci. 2022 Jun 17;23(12):6769.
HepG2 cells 20 µM 24 hours Measurement of H2S production levels showed that chloroxine significantly reduced H2S production Int J Mol Sci. 2022 Jun 17;23(12):6769.
HepG2 cells 15 µM 24 hours Measurement of intracellular amino acid levels showed that chloroxine significantly increased methionine levels and decreased cystathionine levels Int J Mol Sci. 2022 Jun 17;23(12):6769.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CD1 nu/nu mice HGSC intraperitoneal xenograft model Intraperitoneal injection 10 mg/kg Chloroxine once daily, carboplatin once weekly, for 4 weeks To evaluate the synergistic effect of chloroxine with carboplatin in platinum-resistant HGSC mouse model. Results showed that the combination of chloroxine and carboplatin maintained tumor volume at baseline for over 4 months. Cell Death Dis. 2021 Apr 14;12(4):395.
Mice Mdx mouse model In vitro muscle incubation 0.01, 0.1, 1.0, 10, or 100 μM 10 eccentric contractions after 30 min incubation Chloroxine, as a small-molecule inhibitor of RyR1 calcium leak, partially attenuated eccentric contraction-induced force loss in mdx mouse muscle. Skelet Muscle. 2020 Feb 1;10(1):3

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.67mL

0.93mL

0.47mL

23.36mL

4.67mL

2.34mL

46.72mL

9.34mL

4.67mL

References

 

Historical Records

Categories